Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer. Read why OLMA stock is a Hold.

Borland released Turbo Pascal for Windows as Delphi. Many owners have changed since then, but an active community has ...

The first 24 hours of punditry on Judge Stephanos Bibas’s summary judgment of no fair use in Thomson Reuters v. Ross Intelligence, Inc., ...

The geolocated personal data of millions of users is aggregated by data brokers, under dubious conditions. They constitute a ...

Chennai: A stitch in time saves nine. That's why 150 accident "super-hotspots" have been identified in Tamil Nadu and systems ...

Email remains one of the most powerful marketing tools available, delivering some of the highest returns on investment.

A software platform has been launched to improve the registration of tobacco and vape retailers across the country.

NoSQL Market Share The growth of NoSQL industry is augmented by the increase in need for scalable and flexible database solutions in enterp ...

Beyond investor and CEO panic, DeepSeek presents a host of security concerns. Here's what the experts think you should know.

The Company announced today that it has completed its data analytics and the results reflect strong metrics of the DeepView ® System when compared to burn and emergency room physicians in determining ...

AeroLeads, a leading B2B contact database software company, has surpassed $2 million in revenue, solidifying its position as ...

Free vs. paid antivirus software Most free antivirus tools limit the number of devices you can use and/or the features you have access to. If you've got the budget, consider paid antivirus ...